Arrowhead Pharmaceuticals (ARWR) 2025 Conference Transcript

Arrowhead Pharmaceuticals (ARWR) 2025 Conference May 20, 2025 02:35 PM ET Speaker0 Great. Thanks, everybody. Luke Casey, senior biotech analyst here at RBC Capital Market. Today is our great privilege to have Arrowhead Pharmaceuticals as part of our twenty twenty five global health care conference. Representing the company, we have Chris Anzalone, who is the chief executive officer, and we have a very, very long list of questions here. Thank you for joining us. But maybe before we jump into some of the indi ...